Disclosures for "Systemic Complications and Natural History of Aicardi Goutières Syndrome"
-
Mrs. Jan has nothing to disclose.
-
Isabella Barcelos has stock in Petrobras.
-
Mr. Modesti has nothing to disclose.
-
Sarah Woidill has nothing to disclose.
-
Dr. Gavazzi has nothing to disclose.
-
Mr. Isaacs has nothing to disclose.
-
The institution of Mr. D'Aiello has received research support from Takeda Pharmaceuticals. The institution of Mr. D'Aiello has received research support from Orchard Therapeutics.
-
Dr. Sevagamoorthy has nothing to disclose.
-
Mrs. Pizzino has nothing to disclose.
-
Mrs. Schmidt has nothing to disclose.
-
Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viking Therapeutics. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluebirdbio. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orpheris. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME, Inc. The institution of Dr. Van Haren has received research support from Minoryx. The institution of Dr. Van Haren has received research support from bluebirdbio. Dr. Van Haren has a non-compensated relationship as a Board of Directors with ALD Connect that is relevant to AAN interests or activities. Dr. Van Haren has a non-compensated relationship as a Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to AAN interests or activities.
-
Dr. Keller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Veristat, LLC. Dr. Keller has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for United Leukodystrophy Foundation. The institution of Dr. Keller has received research support from CHOP/NIH. The institution of Dr. Keller has received research support from IONIS. The institution of Dr. Keller has received research support from Biomarin. Dr. Keller has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Federal Food and Drug Administration Cellular, Tissue, and Gene Therapies Advisory Committee.
-
An immediate family member of Dr. Eichler has received personal compensation for serving as an employee of UpToDate. Dr. Eichler has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for SwanBio Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Eichler has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Origin Biosciences. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orchard Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Autobahn Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bluebird Bio. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. Dr. Eichler has received stock or an ownership interest from SwanBio Therapeutics. The institution of Dr. Eichler has received research support from Bluebird Bio. The institution of Dr. Eichler has received research support from Minoryx Therpeutics. The institution of Dr. Eichler has received research support from Sio Therapeutics. Dr. Eichler has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Emrick has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Arkema. The institution of Dr. Emrick has received research support from Lysogene. The institution of Dr. Emrick has received research support from PTC. The institution of Dr. Emrick has received research support from Roche. The institution of Dr. Emrick has received research support from NIH.
-
The institution of Dr. Fraser has received research support from NIH.
-
Justine Shults has nothing to disclose.
-
An immediate family member of Dr. Vanderver has received personal compensation for serving as an employee of Maryland Physician Care. The institution of Dr. Vanderver has received research support from Takeda. The institution of Dr. Vanderver has received research support from Passage Bio. The institution of Dr. Vanderver has received research support from Homology. The institution of Dr. Vanderver has received research support from Eli Lilly. The institution of Dr. Vanderver has received research support from Myrtelle. The institution of Dr. Vanderver has received research support from SynaptixBio. The institution of Dr. Vanderver has received research support from PMD Foundation. The institution of Dr. Vanderver has received research support from Ionis. The institution of Dr. Vanderver has received research support from ISD . The institution of Dr. Vanderver has received research support from Boehringer-Ingelheim. The institution of Dr. Vanderver has received research support from Biogen. The institution of Dr. Vanderver has received research support from Sana. The institution of Dr. Vanderver has received research support from Affinia. The institution of Dr. Vanderver has received research support from BridgeBio. The institution of Dr. Vanderver has received research support from Orchard. The institution of Dr. Vanderver has received research support from Minoryx. The institution of Dr. Vanderver has received research support from Forge Biologics. The institution of Dr. Vanderver has received research support from Vigil. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Adang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Development Center Americas, Inc.. Dr. Adang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Middle East Genetics and Metabolic Academy (MEGMA).